Year: 2024

The Company’s rapid alcohol-reducing beverage, Sure Shot, launches in Pete’s Fresh Market, Caputo’s, Tony’s Fresh Market, Festival Foods, and Sunset Foods. JUPITER, Fla., Nov. 01, 2024 (GLOBE NEWSWIRE) — Safety Shot, Inc. (Nasdaq: SHOT) (“Safety Shot” or “the Company”) today announced a significant expansion of its retail footprint with the launch of its 4 oz. Sure Shot beverages in select Chicagoland grocery stores. Sure Shot will be available in all stores of Pete’s Fresh Market, Caputo’s, Tony’s Fresh Market, Festival Foods, and Sunset Foods, with disruptive placements throughout the stores to maximize visibility and consumer awareness. This strategic move into the Chicagoland market represents a key step in Safety Shot’s nationwide expansion strategy. By...

Municipality Finance PlcStock exchange release 1 November 2024 at 3:00 pm (EET) Municipality Finance will redeem early notes issued under its MTN programme Municipality Finance Plc will exercise its right to redeem in whole its EUR 10 million notes (ISIN XS2553828372) on 15 November 2024. The notes are admitted to trading on the Helsinki Stock Exchange maintained by Nasdaq Helsinki. MuniFin has today filed an application to remove the notes from trading. MUNICIPALITY FINANCE PLC Further information: Joakim HolmströmExecutive Vice President, Capital Markets and Sustainabilitytel. +358 50 444 3638 MuniFin (Municipality Finance Plc) is one of Finland’s largest credit institutions. The company is owned by Finnish municipalities, the public sector pension fund Keva and the Republic of Finland. The Group’s balance sheet totals over to EUR...

Common Stock Will Begin Trading on a Split-Adjusted Basis on November 5, 2024 RENO, Nev., Nov. 01, 2024 (GLOBE NEWSWIRE) — Aqua Metals, Inc. (NASDAQ: AQMS), a pioneer in sustainable lithium-ion battery recycling, today announced that it intends to effect a reverse stock split of its common stock at a ratio of 1 post-split share for every 20 pre-split shares. The reverse stock split will become effective at 12:01 a.m. Eastern Time, on November 5, 2024. The Company’s common stock will continue to be traded on the Nasdaq Capital Market under the symbol “AQMS” and will begin trading on a split-adjusted basis when the market opens on November 5, 2024. At a special meeting of stockholders held on October 28, 2024, the Company’s stockholders granted the Company’s Board of Directors the discretion to effect a reverse...

KUALA LUMPUR, Malaysia, Nov. 01, 2024 (GLOBE NEWSWIRE) — VCI Global Limited (NASDAQ: VCIG) (Frankfurt: H0T) (“VCI Global” or the “Company”), a diversified holding company with expertise in consulting, fintech, AI, robotics and cybersecurity, is pleased to announce the approved 1-for-49 stock split of the Company’s common stock with no par value, effective at 12:01 a.m. Eastern Time on 5 November, 2024 (the “Reverse Stock Split”). VCI Global’s common stock will continue to be traded on the Nasdaq Capital Market on a split-adjusted basis beginning on 5 November, 2024, under the Company’s existing trading symbol “VCIG” with the new CUSIP number G98218 202. The Reverse Stock Split is primarily intended to increase the market price per share of the Company’s common stock to regain compliance with the minimum bid price required for continued...

NEWTOWN, PA, Nov. 01, 2024 (GLOBE NEWSWIRE) — Forian Inc. (Nasdaq: FORA), a provider of data science driven information and analytics solutions to the healthcare and life sciences industries, today announced it has acquired Kyber Data Science LLC (“Kyber”), a trusted provider of advanced healthcare data analytics and machine learning solutions to the financial services industry, from TD Cowen. This strategic acquisition strengthens Forian’s position in the healthcare information marketplace through the addition of advanced analytics and software capabilities and expands the industries Forian serves to include financial services. Kyber has established a leading reputation for its innovative approach to real world healthcare data, leveraging cutting-edge analytics to help financial organizations make informed healthcare investment...

COMPANY ANNOUNCEMENT no. 77 – 1 November 2024 EBIT 2024 outlook range lowered to DKK 1.5-1.7bn from DKK 1.7-2.1bn Adjusted free cash flow 2024 outlook is changed to around DKK 1.2bn fromaround DKK 1.5bnDFDS’ EBIT outlook range for 2024 is revised following results below expectations driven by mainly a more widespread slowdown in Europe than previously expected as well as intensified competition in northern European land transport markets and the Mediterranean freight ferry market. The current market conditions are expected to continue for the rest of the year whilst a rebound in activity was previously expected for the rest of the year. The termination of the share purchase agreement to acquire the international transport network of Ekol Logistics, announced earlier today, may moreover in Q4 2024 entail some financial...

COMPANY ANNOUNCEMENT no. 76 – 1 November 2024 In April 2024, DFDS entered into a share purchase agreement to acquire the international transport network of Ekol Logistics. As noted in the company announcement no. 24 of 9 April 2024, completion of the transaction was conditional upon regulatory approvals and certain contractual conditions. As certain contractual conditions have not been satisfied by the agreed deadline, DFDS has terminated the share purchase agreement and the transaction will consequently not take place.Contact Torben Carlsen, CEO +45 33 42 32 01 Karen Boesen, CFO +45 20 58 58 40 Søren Brøndholt Nielsen, IR +45 33 42 33 59 Dennis Kjærsgaard, Media +45 42 30 38 47About DFDS We operate a transport network in and around Europe with an annual revenue of DKK 28bn and 14,000 full-time employees. We move goods...

Recent Medicare Price Assignment Driving Increased Access to CompuFlo Milestone Scientific to Attend New York and New Jersey Pain Medicine Congress 2024 ROSELAND, N.J., Nov. 01, 2024 (GLOBE NEWSWIRE) — Milestone Scientific Inc. (NYSE: MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today announced the commercial rollout of its CompuFlo® Epidural System at Hudson Specialty Care, led by renowned physician Dr. Elbaz. This latest agreement is a direct result of the Company’s recent partnership with Axial Biologics, underscoring the success of this collaboration as Milestone’s sales pipeline expands, with additional pilot programs underway in New Jersey, Texas, and Florida. This agreement also follows CompuFlo’s recent Medicare Part B Physician payment rate with...